Get started
Author

Laëtitia Lambros

Observed names: L Lambros, L. Lambros, Laetitia Lambros
OpenAlex ID: A5010111933
Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day
2017 · Laetitia Lambros, Charline Caumont, et al. · Journal of Clinical Pathology · 40
Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma
2017 · F Barel, B Guibourg, et al. · Acta Dermato Venereologica · 23
Non‐secretory breast carcinomas lack NTRK rearrangements and TRK protein expression
2019 · Annabelle Remoué, Virginie Conan‐Charlet, et al. · Pathology International · 22
Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non–Small-cell Lung Cancer
2018 · Florent Ginestet, Laetitia Lambros, et al. · Clinical Lung Cancer · 13
ROS1-rearranged Non–Small Cell Lung Cancers With Concomitant Oncogenic Driver Alterations: About Some Rare Therapeutic Dilemmas
2017 · Laetitia Lambros, Briac Guibourg, et al. · Clinical Lung Cancer · 9
MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis
2018 · Laetitia Lambros, Arnaud Uguen · Clinical Lung Cancer · 6
Toward a Molecular Diagnosis in a Single Day for Patients With Advanced Non–small-cell Lung Cancer
2018 · Laetitia Lambros, Arnaud Uguen · Clinical Lung Cancer · 6
Un cancer mammaire présentant un réarrangement de NTRK1
2019 · Annabelle Remoué, Virginie Conan-Charlet, et al. · Annales de Pathologie · 3
PDF
Combining ALK Fluorescent In Situ Hybridization and Immunohistochemistry to Analyze Multiple Non–Small Cell Lung Carcinoma Samples per Patient Reveals Intermethod and Intersample-discrepant Results
2018 · Laetitia Lambros, Florent Ginestet, et al. · Applied immunohistochemistry & molecular morphology · 2
The rarity of concomitant genetic alterations in lung cancer
2018 · Laetitia Lambros, Briac Guibourg, et al. · Modern Pathology · 2
PDF
Evaluation of AI-assisted PD-L1 CPS scoring in immunostained pan-organ tumor whole-slide images.
2025 · Céline Bossard, Claire Magois, et al. · Journal of Clinical Oncology · 1
PDF
Evaluation of AI-assisted HER2 scoring in breast carcinoma-stained whole-slide images.
2024 · Florian Thomas, Bénédicte Cormier, et al. · Journal of Clinical Oncology · 1
PDF
PD-L1 Immunohistochemistry-Discrepant Results Between Synchronous Tumor Samples May Cause More Treatment Choice Dilemmas Than Molecular Heterogeneity in Patients With Advanced Non–Small Cell Lung Cancers
2019 · Laetitia Lambros, Isabelle Quintin-Roué, et al. · Applied immunohistochemistry & molecular morphology · 1
Costs of ALK, ROS1, EGFR, and KRAS testing in non–small cell lung cancer: About different strategies in France
2017 · Laetitia Lambros, Briac Guibourg, et al. · Cancer Cytopathology · 1
696 Automated Combined PD-L1 Scoring using Artificial Intelligence on Whole immunohistochemical Slide Image of various carcinoma types
2025 · Florian Thomas, Benedicte Cormier, et al. · Laboratory Investigation
PDF
401P Evaluation of HER2 scoring in breast carcinoma-stained whole slide images
2024 · C. Bossard, Y. Salhi, et al. · Annals of Oncology
PDF
Une lésion sous-muqueuse rare de l’œsophage
2019 · L. Lambros, F. Cholet, et al. · Annales de Pathologie
PDF
NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?
2018 · Laetitia Lambros, Arnaud Uguen · Archives of Pathology & Laboratory Medicine
About MET expression and other biomarkers in non-small cell lung cancer
2017 · Laetitia Lambros, Isabelle Quintin-Roué, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Works count: 20
Citation count: 133
H-index: 6
I10-index: 4
Year
Topic
Type